Loading provider…
Loading provider…
Neurology Physician in Staten Island, NY
NPI: 1295700177Primary Practice Location
RICHMOND UNIVERSITY MEDICAL CENTER
355 Bard Ave, Staten Island, NY
Primary Employer
New Dorp MRI & Imaging
HQ Phone
Get M.D. Allan's Phone Numberphone_androidMobile
Get M.D. Allan's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
Zucker School of Medicine at Hofstra/Northwell
Internship • Internal Medicine
1985 - 1986
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 547 | 810 |
| 2 | 99204New patient office or other outpatient visit, 45-59 minutes | 426 | 426 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 415 | 595 |
| 4 | 95886Needle measurement and recording of electrical activity of muscles of arm or leg complete study | 277 | 678 |
| 5 | 93880Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | 270 | 274 |
Spinal subarachnoid and subdural hematoma presenting as a Brown-Séquard-like myelopathy following minor trauma in a patient on dabigatran etexilate.
Authors: Allen Wolfe
Publication Date: 2016-11-16
Factors associated with benign multiple sclerosis in the New York State MS Consortium (NYSMSC).
Authors: Neil Lava, Bianca Weinstock Guttman, David Snyder, Lauren Krupp
Journal: BMC Neurol
Publication Date: 2016-07-15
Discontinuation of disease modifying therapies is associated with disability progression regardless of prior stable disease and age.
Authors: Bianca Weinstock Guttman, Lauren Krupp
Publication Date: 2021-04-21
Lead Sponsor: ACADIA Pharmaceuticals Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: Pimavanserin 20 mg, DRUG: Pimavanserin 34 mg